These results suggest the possibility of effecting improved immunologic function in PNP-deficient T lymphoid cells by retroviral-mediated gene transfer as therapy for PNP deficiency.
Although no uniform definition exists, the diagnosis of IRIS requires the worsening of a recognized ("paradoxical" IRIS) or unrecognized ("unmasking" IRIS) pre-existing infection in the setting of improving immunologic function.
These effects of tocotrienols may be explained through mechanisms such as antiangiogenesis, antiproliferation, induction of apoptosis, and improving immunologic functions [ 10].
Anti-tumor necrosis factor treatment might improve immunologic features over time and might be considered in patients without vascular manifestations but with elevated inflammation markers.
Furthermore, preclinical work in murine models suggests that local radiotherapy plus intratumoural syngeneic dendritic cells (DC) injection can improve immunologic tumour eradication [ 34].
Additionally, patients receiving MVC had improved immunologic responses, and this advantage was maintained through week 240.
Therefore, the goals of therapy are the prolonged suppression of viral levels to less than detection limits (<50 copies/mL for Amplicor assay, <75 copies/mL for VERSANT assay, and <80 copies/mL for NucliSens assay), with the aim to restore and preserve <span class="lh">immunologic function, improve quality of life, and avoid HIV-associated morbidity and mortality (Gazzard 2005; DHSS 2006).
Studies have also shown that the use of 17β-estradiol (estrogen) after trauma/hemorrhage in male or ovariectomized female rodents improved cardiovascular and immunologic functions and decreased mortality from subsequent sepsis [ 22, 27, 163- 170].
The primary goal of HIV therapy is to increase disease-free survival and improve health-related quality of life (HRQL) by containing viral replication, avoiding drug resistance, and boosting immunologic function by restoring CD4 count [ 1, 2].
We undertook a systematic review of bed-to-benchside studies to test the hypothesis that variable clinical design methodologies used to investigate immunologic function in sepsis contribute to apparently conflicting laboratory data, and identify potential alternatives that overcome various obstacles to improve experimental design.
